PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

Drug side effects

prednisolone Side Effects

The reactions most often reported to the FDA for prednisolone (also sold as Orapred, Pediapred), with demographics, serious outcomes, and reporting trends.

Data updated 2026-05-15

173,227
FAERS reports

Data from the FDA Adverse Event Reporting System (FAERS), 1999 to 2025. A FAERS report records a temporal association, not proof of cause. See our methodology for how figures are compiled and de-duplicated.

The most commonly reported side effects of prednisolone come from 173,227 reports to the FDA, broken down here by frequency, patient demographics, and serious outcomes.

This page analyzes 173,227 reports to the FDA Adverse Event Reporting System (FAERS) for prednisolone (Orapred): the reactions reported most often, who reported them, serious outcomes such as hospitalization, and year-over-year trends. A FAERS report does not prove the drug caused the effect, and report volume tracks how widely a drug is used, not how likely an effect is for any one person. Educational information, not medical advice.

Total Reports

173,227

Reports Mentioning Death

27,831

16.1% of reports — not proof the medicine caused the death

Hospitalizations

79,445

45.9% of reports

Top Indication

Product Used For Unknown Indication

Most Reported Adverse Reactions

PYREXIA
8,197
DYSPNOEA
6,807
PNEUMONIA
6,760
DIARRHOEA
6,510
CONDITION AGGRAVATED
5,688
NAUSEA
5,363
VOMITING
4,963
FATIGUE
4,894
SEPSIS
4,479
HEADACHE
4,466
RASH
4,216
ARTHRALGIA
4,123
MALAISE
4,073
ANAEMIA
3,884
PAIN
3,746
DEATH
3,648
INFECTION
3,314

Who Reports Side Effects

Gender Distribution

Female 82,144 (53%)
Male 71,840 (46%)
Unknown 768

Age Distribution

0-17 13,687 (10%)
18-44 27,176 (21%)
45-64 41,274 (32%)
65-74 26,893 (21%)
75+ 21,626 (17%)

Reporting Trend by Year

1999 2025

Reactions in Death Reports

Top reactions reported in 27,831 reports where death was an outcome. These are voluntarily reported and do not establish causation.

Reaction Reports
DEATH 3,645
PNEUMONIA 2,553
SEPSIS 2,411
PYREXIA 1,690
RESPIRATORY FAILURE 1,648
DYSPNOEA 1,397
DIARRHOEA 1,343
CONDITION AGGRAVATED 1,340
SEPTIC SHOCK 1,323
MULTIPLE ORGAN DYSFUNCTION SYNDROME 1,300
INFECTION 1,182
GENERAL PHYSICAL HEALTH DETERIORATION 1,145
VOMITING 969
INTERSTITIAL LUNG DISEASE 926
FATIGUE 908
MALAISE 855
DISEASE PROGRESSION 842

Reactions in Hospitalization Reports

Top reactions in 79,445 reports where hospitalization was an outcome.

Reaction Reports
PYREXIA 5,881
PNEUMONIA 4,766
DYSPNOEA 4,366
DIARRHOEA 4,024
VOMITING 3,319
NAUSEA 3,020
CONDITION AGGRAVATED 2,934
SEPSIS 2,723
FATIGUE 2,619
GENERAL PHYSICAL HEALTH DETERIORATION 2,589
ANAEMIA 2,454
MALAISE 2,427
HEADACHE 2,349
ACUTE KIDNEY INJURY 2,244
RASH 2,232
ARTHRALGIA 2,206
PAIN 2,171
ABDOMINAL PAIN 2,135

Compare prednisolone vs aclidinium →

What the FAERS Data Reveals About prednisolone Side Effects

The FDA Adverse Event Reporting System (FAERS) contains 173,227 voluntary reports linked to prednisolone and its brand equivalents (Orapred, Pediapred), spanning 1999 through 2025. Of those, 27,831 (16.1%) listed death as an outcome and 79,445 (45.9%) involved hospitalization. The most common indication reported alongside adverse events was Product Used For Unknown Indication.

Demographic breakdowns help contextualize who is being exposed to the drug. Of reports with known sex, 53% were female and 46% male; age distribution skews toward 45-64, with 41,274 reports in that bracket. The single most reported reaction is pyrexia with 8,197 submissions, followed by dyspnoea and pneumonia.

How to read these numbers

FAERS is a signal-detection tool, not a scorecard. Reports are voluntary, and a single case may list multiple suspect drugs, so numbers above should not be read as incidence rates or per-patient risk. Widely prescribed drugs naturally accumulate more reports than niche therapies even when individual risk is low. These aggregates are useful for spotting patterns that merit further pharmacovigilance, not for choosing between medications. This page is for educational reference only and is not medical advice, speak with a licensed clinician about any side-effect concerns.